Capstone Triton Financial Group, LLC Abbott Laboratories Transaction History

Capstone Triton Financial Group, LLC

$147 Million
Q3 2025

A detailed history of Capstone Triton Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Capstone Triton Financial Group, LLC holds 17,513 shares of ABT stock, worth $2.28 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares

17,513

Previous 17,569 0.32%

Holding current value

$2.28 Million

Previous $2.39 Million 1.84%

% of portfolio

1.59%

Previous 1.76%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$120.51 - $136.62 $6,748 - $7,650	-56 Reduced 0.32%	17,513 $2.35 Million
Q2 2025 Jul 30, 2025	SELL	$123.95 - $138.08 $344,704 - $384,000	-2,781 Reduced 13.67%	17,569 $2.39 Million
Q4 2024 Mar 10, 2025	SELL	$111.93 - $119.39 $2,014 - $2,149	-18 Reduced 0.09%	20,350 $2.3 Million
Q3 2024 Oct 25, 2024	SELL	$100.07 - $118.13 $3,302 - $3,898	-33 Reduced 0.16%	20,368 $2.32 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $30,420 - $33,956	302 Added 1.5%	20,401 $2.12 Million

Q1 2024 Apr 19, 2024	SELL	$109.52 - $120.96 $86,958 - $96,042	-794 Reduced 3.8%	20,099 $2.28 Million
Q4 2023 Jan 09, 2024	SELL	$90.19 - $110.4 $316,747 - $387,724	-3,512 Reduced 14.39%	20,893 $2.3 Million
Q3 2023 Oct 11, 2023	BUY	$95.53 - $114.62 $33,817 - $40,575	354 Added 1.47%	24,405 $2.36 Million
Q2 2023 Jul 17, 2023	BUY	$100.78 - $112.29 $9,271 - $10,330	92 Added 0.38%	24,051 $2.62 Million
Q1 2023 Apr 06, 2023	BUY	$96.86 - $114.01 $10,364 - $12,199	107 Added 0.45%	23,959 $2.43 Million
Q4 2022 Jan 17, 2023	BUY	$95.06 - $111.52 $33,271 - $39,032	350 Added 1.49%	23,852 $0
Q3 2022 Oct 28, 2022	SELL	$96.76 - $112.03 $7,450 - $8,626	-77 Reduced 0.33%	23,502 $2.27 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $13,167 - $15,914	-129 Reduced 0.54%	23,579 $2.61 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $2.7 Million - $3.3 Million	23,708 New	23,708 $2.77 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $3.01 Million - $3.69 Million	-26,076 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $52,613 - $58,206	-451 Reduced 1.7%	26,076 $3.3 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $846 - $996	8 Added 0.03%	26,527 $3.08 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $29,931 - $35,263	-275 Reduced 1.03%	26,519 $3.18 Million
Q4 2020 Jan 28, 2021	BUY	$105.0 - $114.42 $2.81 Million - $3.07 Million	26,794 New	26,794 $2.93 Million

Others Institutions Holding ABT

# of Institutions

3,635

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Triton Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Triton Financial Group, LLC with notifications on news.

Account

Capstone Triton Financial Group, LLC Abbott Laboratories Transaction History